Female Genital Neoplasms

Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

Also Known As:

Genital Neoplasms, Female; Neoplasms, Female Genital; Neoplasms, Gynecologic; Female Genital Neoplasm; Genital Neoplasm, Female; Gynecologic Neoplasm; Neoplasm, Female Genital; Neoplasm, Gynecologic; Gynecologic Neoplasms

Networked: 105 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Neoplasms (Cancer)
2.	Endometrial Neoplasms (Endometrial Cancer)
3.	Leiomyoma (Uterine Fibroids)
4.	Carcinoma (Carcinomatosis)
5.	Ovarian Neoplasms (Ovarian Cancer)

Experts

1.	Wei, Jian-Jun: 1 article (01/2022)
2.	Ardila, Edison: 1 article (05/2020)
3.	Pareja, Rene: 1 article (05/2020)
4.	Pecci, Pablo: 1 article (05/2020)
5.	Rodriguez, Juliana: 1 article (05/2020)
6.	Sanabria, Daniel: 1 article (05/2020)
7.	Chang, Ting-Chang: 1 article (10/2019)
8.	Chen, Kueian: 1 article (10/2019)
9.	Cheng, Mei-Ling: 1 article (10/2019)
10.	Cheng, Shih-Chun: 1 article (10/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Female Genital Neoplasms:

1.	Raloxifene Hydrochloride (Evista)FDA Link 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
2.	Selective Estrogen Receptor Modulators (SERM)IBA 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
3.	Tamoxifen FDA LinkGeneric 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
4.	Estrogen AntagonistsIBA 11/01/1996 - "These data indicate that SERMs such as raloxifene and tamoxifen act as estrogen antagonists in uterine myometrial cells and suggest that this class of compounds may be effective for treatment of this important gynecologic neoplasm."
5.	Biomarkers (Surrogate Marker)IBA 01/01/2022 - "In this article, we review recent developments in the study of HMGA2 and its expression as a potential biomarker for gynecologic neoplasms and clinic application." 01/01/2018 - "Serum hormonal biomarkers have clinical utility both in the diagnosis of gynecologic neoplasms and clinical monitoring of treatment efficacy and recurrence." 10/22/2016 - "In gynecologic neoplasms, determination of HER2/neu status has not been well studied as a predictive biomarker in anti-HER2/neu treatment. " 10/29/2019 - "Endometrial cancer (EC) is one of the most common gynecologic neoplasms in developed countries but lacks screening biomarkers. " 01/01/2018 - "This review will discuss gynecologic neoplasms that produce hormonal biomarkers and assess their relevance to pathological diagnosis, evaluation for therapeutic response and monitoring disease progression. "
6.	RadiumIBA 10/28/1971 - "[Studies with computers of the dosage distribution in the pelvis under intracavital radium treatment of gynecologic neoplasms]." 10/01/1973 - "[Colposcopy and colpocytology after radium treatment of gynecologic neoplasms]." 07/01/1964 - "[THE EFFECT OF COMBINED RADIUM-TELECOBALT IRRADIATION OF GYNECOLOGIC NEOPLASMS ON THE BLOOD COAGULATION SYSTEM]."
7.	Estrogens (Estrogen)FDA Link 12/04/1975 - "When estrogen use was adjusted for concomitant variables such as obesity, hypertension, diabetes, parity, referral pattern, age at diagnosis, year of diagnosis and other gynecologic neoplasms, the magnitude of the increased relative risk was associated with several of these variables, and was highest in patients without obesity and hypertension. " 12/04/1975 - "To determine the association between the incidence of endometrial cancer and the use of estrogen in menopausal and post-menopausal women, we retrospectively compared 317 patients with adenocarcinoma of the endometrium with an equal number of matched controls having other gynecologic neoplasms; 152 patients used estrogen, as compared to 54 of 317 controls. " 04/01/1987 - "A study of cytoplasmic and nuclear estrogen and progestin receptors in gynecologic neoplasms." 10/01/2019 - "Cadmium (Cd) is a ubiquitous environmental metal that is reported to be a "metalloestrogen." Uterine leiomyomas (fibroids) are estrogen-responsive gynecologic neoplasms that can be the target of xenoestrogens. "
8.	Progesterone Receptors (Progesterone Receptor)IBA 04/01/1987 - "A study of cytoplasmic and nuclear estrogen and progestin receptors in gynecologic neoplasms."
9.	Hydroxyurea (Hydrea)FDA LinkGeneric 08/01/1964 - "PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: UROLOGIC AND GYNECOLOGIC NEOPLASMS."
10.	Cytostatic AgentsIBA 01/01/1990 - "[Gastrointestinal side effects of cytostatic treatment of gynecologic neoplasms]." 07/01/1973 - "[Incidence of bacterial flora in the vagina and urine in patients with gynecologic neoplasms during short-term administration of cytostatics]." 07/01/1991 - "[Cytostatic polychemotherapy plans integrated into the multimodal treatment of malignant gynecologic neoplasms. " 01/01/1991 - "[Locoregional ascites therapy with cytostatic drugs and immune modulators in gynecologic neoplasms]." 01/01/1983 - "[Urinary enzyme excretion in cytostatic and radiotherapy of gynecologic neoplasms]."

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 07/01/1986 - "[Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms]." 03/17/1962 - "[Experimental studies on selective chemotherapy of gynecologic neoplasms]." 07/25/1970 - "[Chemotherapy of malignant gynecologic neoplasms]." 08/31/1965 - "[Onco-chemotherapy by introduction into retzius space in treatment of female genital neoplasms]." 11/01/1992 - "[Intra-arterial infusion chemotherapy of female genital neoplasms]."
2.	Pelvic Exenteration 01/01/2019 - "This study is aimed to assess the prevalence of unanticipated gynecologic neoplasms in anterior pelvic exenteration specimens. "
3.	Therapeutics 01/01/2019 - "Lineage-Specific Alterations in Gynecologic Neoplasms with Choriocarcinomatous Differentiation: Implications for Origin and Therapeutics." 01/01/1989 - "[A comparison between the dose distribution from 192Ir point and line sources in the afterloading therapy of gynecologic neoplasms]." 10/15/1987 - "In order to justify the utilization of surgical staging for gynecologic neoplasms, it is necessary to demonstrate a survival advantage in patients where the precise extent of disease has been established and subsequent therapy tailored accordingly. " 12/12/1967 - "[Intralymphatic therapy with P32 in female genital neoplasms]." 10/01/2023 - "Our review thereby aimed to provide an overview of the biological involvement of TRIMs in female genital neoplasms, to provide a better understanding of its role in the development and progression of such diseases, and emphasize its potential as targeted cancer therapy. "
4.	Radiotherapy 01/01/1973 - "[Current dosimetry within the scope of radiotherapy for gynecologic neoplasms]." 05/16/1968 - "[Treatment of intestinal disorders caused by radiations in patients during ionizing radiotherapy of gynecologic neoplasms]." 07/01/2005 - "Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms." 01/01/1993 - "Radiotherapy versus radical surgery for gynecologic neoplasms: carcinomas of the cervix and vulva." 06/12/1965 - "[Femoral neck fractures caused by radiotherapy of gynecologic neoplasms. "
5.	Hysterectomy 08/01/2014 - "Uterine fibroids are the most common type of benign, gynecologic neoplasm and are the primary indication for performance of a hysterectomy, accounting for >200,000 hysterectomies annually in the USA. " 07/01/2000 - "Uterine leiomyoma are the most common gynecologic neoplasm and a primary cause of hysterectomy in premenopausal women. " 05/01/2020 - "The search included the following medical subject heading terms and keywords: "same day discharge," "patient discharge," "minimally invasive surgical procedures," "hysterectomy," "gynecologic malignancy," "gynecologic neoplasm," "cervical cancer," "ovarian cancer," and "endometrial cancer." Articles published in English about women who underwent minimally invasive procedures for benign and malignant conditions of the reproductive tract performed by gynecologic oncologists (robotic or laparoscopic) and who received SDD or admission were included. "